Maeda, S.; Sugimoto, M.; Tenma, Y.; Tsukitome, H.; Kato, K.; Chujo, S.; Matsui, Y.; Matsubara, H.; Kondo, M.
Response to Initial Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema Is Significantly Correlated with Response to Third Consecutive Monthly Injection. J. Clin. Med. 2022, 11, 6416.
https://doi.org/10.3390/jcm11216416
AMA Style
Maeda S, Sugimoto M, Tenma Y, Tsukitome H, Kato K, Chujo S, Matsui Y, Matsubara H, Kondo M.
Response to Initial Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema Is Significantly Correlated with Response to Third Consecutive Monthly Injection. Journal of Clinical Medicine. 2022; 11(21):6416.
https://doi.org/10.3390/jcm11216416
Chicago/Turabian Style
Maeda, Satoshi, Masahiko Sugimoto, Yumiho Tenma, Hideyuki Tsukitome, Kumiko Kato, Shinichiro Chujo, Yoshitsugu Matsui, Hisashi Matsubara, and Mineo Kondo.
2022. "Response to Initial Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema Is Significantly Correlated with Response to Third Consecutive Monthly Injection" Journal of Clinical Medicine 11, no. 21: 6416.
https://doi.org/10.3390/jcm11216416
APA Style
Maeda, S., Sugimoto, M., Tenma, Y., Tsukitome, H., Kato, K., Chujo, S., Matsui, Y., Matsubara, H., & Kondo, M.
(2022). Response to Initial Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema Is Significantly Correlated with Response to Third Consecutive Monthly Injection. Journal of Clinical Medicine, 11(21), 6416.
https://doi.org/10.3390/jcm11216416
